Objectives

After participating in this educational activity, attendees should be able to:
1. Identify the two types of statistical errors inherent in clinical research. 
2. Analyze the ethical and pratical issues surrounding risk to subjects that investigators should make when designing and implementing SBER research protocols. 
3. Discuss the distinction between "statistical significance" and "clinical significance".
4. Identify and analyze Institutional Review Board's assessment of ethical and regulatory responsibilities in review of Human Subjects Research.
5. Describe the relationship between sample size and statistical power.
6. Describe investigator's responsibilities when conducting a clinical trial.

Jennifer Pacheco, MPH
Director, Human Research Protection Program
Baystate Health

Paul Visintainer, PhD
Professor of Medicine
University of Massachusetts Medical School-Baystate
Director of Scientific Integrity & Analytics, Epidemiology & Biostatistics
Baystate Health

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.